Davenport & CO LLC Ionis Pharmaceuticals Inc Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

A detailed history of Davenport & CO LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Davenport & CO LLC holds 80,678 shares of IONS stock, worth $3.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

80,678

Previous 83,928 3.87%

Holding current value

$3.4 Million

Previous $3.64 Million 5.69%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$36.45 - $47.7 $118,462 - $155,025	-3,250 Reduced 3.87%	80,678 $3.85 Million
Q1 2024 May 03, 2024	SELL	$42.03 - $53.55 $100,872 - $128,520	-2,400 Reduced 2.78%	83,928 $3.64 Million
Q4 2023 Jan 23, 2024	SELL	$43.39 - $51.63 $23,821 - $28,344	-549 Reduced 0.63%	86,328 $4.37 Million
Q3 2023 Oct 17, 2023	SELL	$38.5 - $47.13 $36,190 - $44,302	-940 Reduced 1.07%	86,877 $3.94 Million
Q2 2023 Jul 20, 2023	BUY	$34.73 - $43.33 $250,055 - $311,976	7,200 Added 8.93%	87,817 $3.6 Million
Q4 2022 Jan 20, 2023	SELL	$37.12 - $46.52 $157,611 - $197,523	-4,246 Reduced 5.0%	80,617 $0
Q3 2022 Oct 11, 2022	BUY	$36.54 - $48.66 $56,454 - $75,179	1,545 Added 1.85%	84,863 $3.75 Million
Q2 2022 Jul 18, 2022	SELL	$31.71 - $43.0 $17,281 - $23,435	-545 Reduced 0.65%	83,318 $3.08 Million
Q1 2022 May 02, 2022	SELL	$29.88 - $37.04 $23,904 - $29,632	-800 Reduced 0.94%	83,863 $3.11 Million
Q4 2021 Feb 10, 2022	SELL	$25.61 - $35.1 $963,960 - $1.32 Million	-37,640 Reduced 30.78%	84,663 $2.58 Million
Q3 2021 Oct 14, 2021	BUY	$33.54 - $40.55 $179,103 - $216,536	5,340 Added 4.57%	122,303 $4.1 Million
Q2 2021 Jul 28, 2021	SELL	$34.54 - $47.25 $268,548 - $367,368	-7,775 Reduced 6.23%	116,963 $4.66 Million
Q1 2021 Apr 28, 2021	BUY	$42.51 - $63.78 $110,526 - $165,828	2,600 Added 2.13%	124,738 $5.61 Million
Q4 2020 Jan 13, 2021	SELL	$45.3 - $60.27 $18,120 - $24,108	-400 Reduced 0.33%	122,138 $6.91 Million
Q3 2020 Oct 15, 2020	SELL	$47.45 - $62.95 $191,603 - $254,192	-4,038 Reduced 3.19%	122,538 $5.81 Million
Q2 2020 Jul 28, 2020	SELL	$46.85 - $61.05 $480,212 - $625,762	-10,250 Reduced 7.49%	126,576 $7.46 Million
Q1 2020 May 05, 2020	SELL	$41.6 - $63.4 $3.29 Million - $5.01 Million	-79,086 Reduced 36.63%	136,826 $6.47 Million
Q4 2019 Jan 22, 2020	BUY	$53.85 - $65.27 $3.76 Million - $4.55 Million	69,746 Added 47.72%	215,912 $13 Million
Q2 2019 Jul 10, 2019	SELL	$62.09 - $86.14 $1.78 Million - $2.47 Million	-28,636 Reduced 16.38%	146,166 $9.39 Million
Q1 2019 Apr 17, 2019	SELL	$52.92 - $81.17 $2.71 Million - $4.15 Million	-51,165 Reduced 22.64%	174,802 $14.2 Million
Q4 2018 Jan 28, 2019	BUY	$43.37 - $59.54 $477,416 - $655,416	11,008 Added 5.12%	225,967 $12.2 Million
Q3 2018 Oct 11, 2018	BUY	$42.88 - $53.7 $1.46 Million - $1.83 Million	34,022 Added 18.8%	214,959 $11.1 Million
Q2 2018 Jul 09, 2018	BUY	$40.53 - $50.7 $3.33 Million - $4.17 Million	82,247 Added 83.34%	180,937 $7.54 Million
Q1 2018 Apr 04, 2018	BUY	$44.08 - $55.05 $1.61 Million - $2.01 Million	36,545 Added 58.81%	98,690 $4.35 Billion
Q4 2017 Jan 17, 2018	BUY	$50.3 - $64.39 $1.47 Million - $1.88 Million	29,245 Added 88.89%	62,145 $3.13 Billion
Q3 2017 Oct 12, 2017	BUY	$45.56 - $59.57 $1.5 Million - $1.96 Million	32,900	32,900 $1.67 Billion

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.99B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account